Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Sep;37(9):1018–1021. doi: 10.1136/jcp.37.9.1018

Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.

S A Walker, T R Rogers, P G Riches, S White, J R Hobbs
PMCID: PMC498918  PMID: 6381551

Abstract

Serum C-reactive protein concentrations were measured serially during the early transplant period in 68 bone marrow recipients transplanted for leukaemia (34), chronic granulocytic leukaemia (2), severe aplastic anaemia (6), and various inborn errors of metabolism (26). There were 116 clearly documented episodes of infection or acute graft versus host disease or both. Serum C-reactive protein concentrations in patients with viral (11) or fungal infection (6) were normal or only slightly raised. In 32 patients with isolated acute graft versus host disease, only three (10%) showed serum C-reactive protein concentrations above 40 mg/l. Values greater than 40 mg/l were strongly suggestive of bacterial infections and values above 100 mg/l were seen only in patients (43) with bacterial infections with or without acute graft versus host disease. These findings suggest that serum C-reactive protein concentrations are valuable both for diagnosis and monitoring of such infections.

Full text

PDF
1018

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrett A. J., Kendra J. R., Lucas C. F., Joss D. V., Joshi R., Pendharkar P., Hugh-Jones K. Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients. Br Med J (Clin Res Ed) 1982 Jul 17;285(6336):162–166. doi: 10.1136/bmj.285.6336.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buckell N. A., Lennard-Jones J. E., Hernandez M. A., Kohn J., Riches P. G., Wadsworth J. Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut. 1979 Jan;20(1):22–27. doi: 10.1136/gut.20.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clarke D., Cost K. Use of serum C-reactive protein in differentiating septic from aseptic meningitis in children. J Pediatr. 1983 May;102(5):718–720. doi: 10.1016/s0022-3476(83)80242-x. [DOI] [PubMed] [Google Scholar]
  4. Dowling J. N., Wu B. C., Armstrong J. A., Ho M. Enhancement of murine cytomegalovirus infection during graft-vs.-host reaction. J Infect Dis. 1977 Jun;135(6):990–994. doi: 10.1093/infdis/135.6.990. [DOI] [PubMed] [Google Scholar]
  5. Fischer C. L., Gill C., Forrester M. G., Nakamura R. Quantitation of "acute-phase proteins" postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol. 1976 Nov;66(5):840–846. doi: 10.1093/ajcp/66.5.840. [DOI] [PubMed] [Google Scholar]
  6. Gewurz H., Mold C., Siegel J., Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med. 1982;27:345–372. [PubMed] [Google Scholar]
  7. James W. D., Odom R. B. Graft-v-host disease. Arch Dermatol. 1983 Aug;119(8):683–689. [PubMed] [Google Scholar]
  8. Jones J. M., Wilson R., Bealmear P. M. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res. 1971 Mar;45(3):577–588. [PubMed] [Google Scholar]
  9. Kendra J., Barrett A. J., Lucas C., Joshi R., Joss V., Desai M., Halil O., Rogers T. R., Hobbs J. R., Hugh-Jones K. Response of graft versus host disease to high doses of methyl prednisolone. Clin Lab Haematol. 1981;3(1):19–26. doi: 10.1111/j.1365-2257.1981.tb01305.x. [DOI] [PubMed] [Google Scholar]
  10. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39–48. doi: 10.1111/j.1749-6632.1982.tb22124.x. [DOI] [PubMed] [Google Scholar]
  11. McCarthy P. L., Frank A. L., Ablow R. C., Masters S. J., Dolan T. F., Jr Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia. J Pediatr. 1978 Mar;92(3):454–456. doi: 10.1016/s0022-3476(78)80448-x. [DOI] [PubMed] [Google Scholar]
  12. Peltola H. C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report. J Pediatr. 1983 May;102(5):713–715. doi: 10.1016/s0022-3476(83)80240-6. [DOI] [PubMed] [Google Scholar]
  13. Pollard M., Chang C. F., Srivastava K. K. The role of microflora in development of graft-versus-host disease. Transplant Proc. 1976 Dec;8(4):533–536. [PubMed] [Google Scholar]
  14. Rogers T. R. Infection complicating bone marrow transplantation: what are the risks and can they be reduced? J Hosp Infect. 1982 Jun;3(2):105–109. doi: 10.1016/0195-6701(82)90002-0. [DOI] [PubMed] [Google Scholar]
  15. Rose H. D., Varkey B. Deep mycotic infection in the hospitalized adult: a study of 123 patients. Medicine (Baltimore) 1975 Nov;54(6):499–507. doi: 10.1097/00005792-197511000-00004. [DOI] [PubMed] [Google Scholar]
  16. Rose P. E., Johnsdon S. A., Meakin M., Mackie P. H., Stuart J. Serial study of C-reactive protein during infection in leukaemia. J Clin Pathol. 1981 Mar;34(3):263–266. doi: 10.1136/jcp.34.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rowe I. F., Worsley A. M., Donnelly P., Catovsky D., Goldman J. M., Galton D., Pepys M. B. Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia. J Clin Pathol. 1984 Mar;37(3):263–266. doi: 10.1136/jcp.37.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sabel K. G., Wadsworth C. C-reactive protein (CRP) in early diagnosis of neonatal septicemia. Acta Paediatr Scand. 1979 Nov;68(6):825–831. doi: 10.1111/j.1651-2227.1979.tb08219.x. [DOI] [PubMed] [Google Scholar]
  19. Schofield K. P., Voulgari F., Gozzard D. I., Leyland M. J., Beeching N. J., Stuart J. C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol. 1982 Aug;35(8):866–869. doi: 10.1136/jcp.35.8.866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shine B., de Beer F. C., Pepys M. B. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta. 1981 Nov 25;117(1):13–23. doi: 10.1016/0009-8981(81)90005-x. [DOI] [PubMed] [Google Scholar]
  21. Storb R., Prentice R. L., Buckner C. D., Clift R. A., Appelbaum F., Deeg J., Doney K., Hansen J. A., Mason M., Sanders J. E. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med. 1983 Feb 10;308(6):302–307. doi: 10.1056/NEJM198302103080602. [DOI] [PubMed] [Google Scholar]
  22. Sullivan K. M., Parkman R. The pathophysiology and treatment of graft-versus-host disease. Clin Haematol. 1983 Oct;12(3):775–789. doi: 10.1016/s0308-2261(83)80010-1. [DOI] [PubMed] [Google Scholar]
  23. Walker S. A., Riches P. G., Rogers T. R., White S., Hobbs J. R. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period. J Clin Pathol. 1984 Sep;37(9):1022–1026. doi: 10.1136/jcp.37.9.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Watson J. G. Problems of infection after bone marrow transplantation. J Clin Pathol. 1983 Jun;36(6):683–692. doi: 10.1136/jcp.36.6.683. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES